Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F Patterson

Showing results (131-140 of 204) with videos related to

Pageof 21
Sort By:
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Standardization of an experimental murine model of invasive pulmonary aspergillosisDonald C Sheppard, John R Graybill, Laura K Najvar, et al.
Cancer|November 15, 2006
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosisJohan Maertens, Axel Glasmacher, Raoul Herbrecht, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of CryptococcosisKristy Koselny, Julianne Green, Louis DiDone, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2009
Inhaled voriconazole for prevention of invasive pulmonary aspergillosisJustin A Tolman, Nathan P Wiederhold, Jason T McConville, et al.
BMC Infectious Diseases|May 30, 2019
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 dataJie Jin, Depei Wu, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2008
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative cultureAna C Vallor, William R Kirkpatrick, Laura K Najvar, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.
Medical Mycology|April 8, 2010
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patientSteven D Westbrook, Nathan P Wiederhold, Ana C Vallor, et al.
Pageof 21

Showing results (131-140 of 204) with videos related to

Sort By:
Pageof 21
Antimicrobial Agents and Chemotherapy|June 28, 2017
Prophylactic Treatment with VT-1161 Protects Immunosuppressed Mice from Rhizopus arrhizus var. arrhizus InfectionTeclegiorgis Gebremariam, Sondus Alkhazraji, Lin Lin, et al.
Antimicrobial Agents and Chemotherapy|September 29, 2006
Standardization of an experimental murine model of invasive pulmonary aspergillosisDonald C Sheppard, John R Graybill, Laura K Najvar, et al.
Cancer|November 15, 2006
Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosisJohan Maertens, Axel Glasmacher, Raoul Herbrecht, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
The Celecoxib Derivative AR-12 Has Broad-Spectrum Antifungal Activity In Vitro and Improves the Activity of Fluconazole in a Murine Model of CryptococcosisKristy Koselny, Julianne Green, Louis DiDone, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2014
The investigational agent E1210 is effective in treatment of experimental invasive candidiasis caused by resistant Candida albicansNathan P Wiederhold, Laura K Najvar, Annette W Fothergill, et al.
Antimicrobial Agents and Chemotherapy|March 18, 2009
Inhaled voriconazole for prevention of invasive pulmonary aspergillosisJustin A Tolman, Nathan P Wiederhold, Jason T McConville, et al.
BMC Infectious Diseases|May 30, 2019
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 dataJie Jin, Depei Wu, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|May 14, 2008
Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative cultureAna C Vallor, William R Kirkpatrick, Laura K Najvar, et al.
Antimicrobial Agents and Chemotherapy|February 14, 2018
The Novel Fungal Cyp51 Inhibitor VT-1598 Is Efficacious in Experimental Models of Central Nervous System Coccidioidomycosis Caused by Coccidioides posadasii and Coccidioides immitisNathan P Wiederhold, Lisa F Shubitz, Laura K Najvar, et al.
Medical Mycology|April 8, 2010
Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patientSteven D Westbrook, Nathan P Wiederhold, Ana C Vallor, et al.
Pageof 21